These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6166775)

  • 1. [A quantitative immunofluorometric assay for alpha-fetoprotein and antibodies to varicella-zoster virus in human serum (author's transl)].
    Ogata M; Yasunaga Y; Abe K
    Rinsho Byori; 1980 Sep; 28(9):856-63. PubMed ID: 6166775
    [No Abstract]   [Full Text] [Related]  

  • 2. A single serum dilution method for the quantitation of neutralizing antibodies to varicella-zoster virus.
    Takayama M; Oya A
    Biken J; 1981 Sep; 24(3):109-18. PubMed ID: 6279092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of human alpha, beta and gamma interferons on varicella zoster virus in vitro.
    Balachandra K; Thawaranantha D; Ayuthaya PI; Bhumisawasdi J; Shiraki K; Yamanishi K
    Southeast Asian J Trop Med Public Health; 1994 Jun; 25(2):252-7. PubMed ID: 7855636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the viral etiology of Bell's palsy (An enzyme-linked immunosorbent assay study) (author's transl)].
    Mees K; Wolf H; Roggendorf M
    Laryngol Rhinol Otol (Stuttg); 1981 Dec; 60(12):609-11. PubMed ID: 6285096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The elimination of nonspecific reaction in ELISA --for the application of routine serological test on varicella zoster, measles and rubella virus (author's transl)].
    Mizutani C; Hirayama M; Minamitani M
    Kansenshogaku Zasshi; 1981 Mar; 55(3):143-8. PubMed ID: 6268717
    [No Abstract]   [Full Text] [Related]  

  • 6. [Facial paralysis and varicella-zoster virus (VZV): serum antibody titer and VZV skin test (author's transl)].
    Ogino S
    Nihon Jibiinkoka Gakkai Kaiho; 1980; 83(2):186-200. PubMed ID: 6248622
    [No Abstract]   [Full Text] [Related]  

  • 7. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
    Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Kawakami K; Takahashi M
    Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella-zoster antibodies in patients with Hodgkin's disease.
    Trlifajová J; Lukásová M; Hrdlicková N
    Neoplasma; 1980; 27(6):751-2. PubMed ID: 6265816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells.
    Zaia JA; Oxman MN
    J Infect Dis; 1977 Oct; 136(4):519-30. PubMed ID: 198487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test.
    Sauerbrei A; Färber I; Brandstädt A; Schacke M; Wutzler P
    J Virol Methods; 2004 Jul; 119(1):25-30. PubMed ID: 15109817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live attenuated varicella vaccine: the KMcC strain in healthy children.
    Arbeter AM; Starr SE; Weibel RE; Neff BJ; Plotkin SA
    Pediatrics; 1983 Mar; 71(3):307-12. PubMed ID: 6298698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of varicella-zoster virus (VZV)-specific antibodies in the early phase of varicella in immunocompromized children.
    Nyerges G; Mészner Z; Simon M
    Acta Microbiol Hung; 1983; 30(3-4):211-5. PubMed ID: 6326459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternally acquired varicella-zoster virus antibodies disappear at 6 months of age in prematurely born children.
    Akisu M; Yalaz M; Aksu G; Arslanoglu S; Genel F; Kutukculer N; Kultursay N
    Panminerva Med; 2003 Jun; 45(2):155-6. PubMed ID: 12855941
    [No Abstract]   [Full Text] [Related]  

  • 14. Varicella zoster in hospital personnel: skin test reactivity to monitor susceptibility.
    Steele RW; Coleman MA; Fiser M; Bradsher RW
    Pediatrics; 1982 Oct; 70(4):604-8. PubMed ID: 6289236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Several methods of detecting varicella-zoster virus (VZV) and measuring VZV immune status.
    Osborne TA; Thomson RB; Bostick CC; Congeni BL
    Diagn Microbiol Infect Dis; 1989; 12(3):287-8. PubMed ID: 2551571
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of a new latex agglutination assay with indirect immunofluorescence to detect varicella-zoster antibodies.
    Zbinden R; Wehrli M; Heinzer I
    Diagn Microbiol Infect Dis; 1994 Oct; 20(2):117. PubMed ID: 7867305
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid enzyme-linked immunosorbent assay for detecting antibody to varicella-zoster virus.
    Demmler GJ; Steinberg SP; Blum G; Gershon AA
    J Infect Dis; 1988 Jan; 157(1):211-2. PubMed ID: 2826610
    [No Abstract]   [Full Text] [Related]  

  • 18. [An immunological study of herpes zoster patients III--specific immunity (author's transl)].
    Vacek Z; Trlifajová J; Doutlík S; Vasícková M; Ryba M
    Cesk Dermatol; 1981 Feb; 56(1):11-6. PubMed ID: 6260390
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of humoral immunity to varicella-zoster virus by an enhanced neutralization test and by the fluorescent antibody to membrane antigen test.
    Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Takahashi M
    Arch Virol; 1983; 75(3):225-8. PubMed ID: 6301406
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and evaluation of Varicella zoster virus ELISA for oral fluid suitable for epidemiological studies.
    Talukder Y; Gopal R; Andrews N; Glenn M; Breuer J; Brown D
    J Virol Methods; 2005 Sep; 128(1-2):162-7. PubMed ID: 15961168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.